Evidence map›Paper›PMID 38923198›Full record

ArticleCancer medicine2024

Adaption of neurosurgical resection patterns for pediatric low-grade glioma spanning two decades-Report from the German LGG-studies 1996-2018.

Tibor Kelety, Ulrich-Wilhelm Thomale, Daniela Kandels, Martin U Schuhmann, Ahmed El Damaty, Jürgen Krauss, Michael C Frühwald, Pablo Hernáiz Driever, Olaf Witt, Brigitte Bison and 4 more

Abstract read
In one paragraph

Article in Cancer medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Tibor KeletyPediatrics and Adolescent Medicine, Swabian Children's Cancer Center, University Hospital Augsburg, Augsburg, Germany.
Ulrich-Wilhelm ThomalePediatric Neurosurgery, Campus Virchow Klinikum, Charité - Universitaetsmedizin Berlin, Berlin, Germany.
Daniela KandelsPediatrics and Adolescent Medicine, Swabian Children's Cancer Center, University Hospital Augsburg, Augsburg, Germany.ORCID 0000-0002-8631-868X
Martin U SchuhmannDivision of Pediatric Neurosurgery, Department of Neurosurgery, University Hospital of Tuebingen, Eberhard Karls University, Tuebingen, Germany.
Ahmed El DamatyDivision of Pediatric Neurosurgery, Department of Neurosurgery, Heidelberg University, Heidelberg, Germany.
Jürgen KraussDepartment of Pediatric Neurosurgery, University Children's Hospital, University of Würzburg, Würzburg, Germany.
Michael C FrühwaldPediatrics and Adolescent Medicine, Swabian Children's Cancer Center, University Hospital Augsburg, Augsburg, Germany.ORCID 0000-0002-8237-1854
Pablo Hernáiz DrieverDepartment of Pediatric Oncology and Hematology, Charité - Universitaetsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ), Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg University Hospital, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Brigitte BisonDiagnostic and Interventional Neuroradiology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
Monika Warmuth-MetzInstitute of Diagnostic and Therapeutic Neuroradiology, University Hospital Würzburg, Würzburg, Germany.
Torsten PietschDepartment of Neuropathology and DGNN Brain Tumor Reference Center, University of Bonn Medical Center, Bonn, Germany.
René SchmidtInstitute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany.
Astrid K GnekowPediatrics and Adolescent Medicine, Swabian Children's Cancer Center, University Hospital Augsburg, Augsburg, Germany.ORCID 0000-0002-7356-6887

Funding

German Cancer Aid (Deutsche Krebshilfe) 70-2218-Gn1German Children's Cancer Foundation (Deutsche Kinderkrebsstiftung) 2004.5German Children's Cancer Foundation (Deutsche Kinderkrebsstiftung) 2007.10German Children's Cancer Foundation (Deutsche Kinderkrebsstiftung) 2010.08German Children's Cancer Foundation (Deutsche Kinderkrebsstiftung) 2011.16German Children's Cancer Foundation (Deutsche Kinderkrebsstiftung) 2013.19German Children's Cancer Foundation (Deutsche Kinderkrebsstiftung) 2015.1
6 · The paper itself

Abstract

introductionNeurosurgery is considered the mainstay of treatment for pediatric low-grade glioma (LGG); the extent of resection determines subsequent stratification in current treatment protocols. Yet, surgical radicality must be balanced against the risks of complications that may affect long-term quality of life. We investigated whether this consideration impacted surgical resection patterns over time for patients of the German LGG studies. PATIENTS AND

methodsFour thousand two hundred and seventy pediatric patients from three successive LGG studies (median age at diagnosis 7.6 years, neurofibromatosis (NF1) 14.7%) were grouped into 5 consecutive time intervals (TI1-5) for date of diagnosis and analyzed for timing and extent of first surgery with respect to tumor site, histology, NF1-status, sex, and age.

resultsThe fraction of radiological LGG diagnoses increased over time (TI1 12.6%; TI5 21.7%), while the extent of the first neurosurgical intervention (3440/4270) showed a reduced fraction of complete/subtotal and an increase of partial resections from TI1 to TI5. Binary logistic regression analysis for the first intervention within the first year following diagnosis confirmed the temporal trends (p < 0.001) and the link with tumor site for each extent of resection (p < 0.001). Higher age is related to more complete resections in the cerebellum and cerebral hemispheres.

conclusionsThe declining extent of surgical resections over time was unrelated to patient characteristics. It paralleled the evolution of comprehensive treatment algorithms; thus, it may reflect alignment of surgical practice to recommendations in respect to age, tumor site, and NF1-status integrated as such into current treatment guidelines. Further investigations are needed to understand how planning, performance, or tumor characteristics impact achieving surgical goals.

Indexed as

Brain NeoplasmsGliomaNeurosurgical ProceduresAdolescentChildChild, PreschoolFemaleGermanyHumansInfantMaleNeoplasm Gradingchildextent of resectionlow‐grade gliomaneurosurgerytreatment algorithm

Identifiers

PMID38923198
PMCPMC11194681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.